Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Elborn

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
BMJ Open Respiratory Research|January 29, 2019
British Thoracic Society guideline for bronchiectasis in adultsAdam T Hill, Anita L Sullivan, James D Chalmers, et al.
ERJ Open Research|April 26, 2021
BronchUK: protocol for an observational cohort study and biobank in bronchiectasisAnthony De Soyza, Philip Mawson, Adam T Hill, et al.
Heliyon|February 2, 2024
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020-2021Michelle K Greene, Peter Smyth, Andrew English, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
The Lancet. Respiratory Medicine|April 27, 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)James D Chalmers, Eva Polverino, Megan L Crichton, et al.
The European Respiratory Journal|June 12, 2025
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trialBarry J Plant, Gisli G Einarsson, Kevin F Deasy, et al.
Microbiome|April 3, 2020
Lung function and microbiota diversity in cystic fibrosisLeah Cuthbertson, Alan W Walker, Anna E Oliver, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.
The European Respiratory Journal|September 11, 2017
European Respiratory Society guidelines for the management of adult bronchiectasisEva Polverino, Pieter C Goeminne, Melissa J McDonnell, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
BMJ Open Respiratory Research|January 29, 2019
British Thoracic Society guideline for bronchiectasis in adultsAdam T Hill, Anita L Sullivan, James D Chalmers, et al.
ERJ Open Research|April 26, 2021
BronchUK: protocol for an observational cohort study and biobank in bronchiectasisAnthony De Soyza, Philip Mawson, Adam T Hill, et al.
Heliyon|February 2, 2024
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020-2021Michelle K Greene, Peter Smyth, Andrew English, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
The Lancet. Respiratory Medicine|April 27, 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)James D Chalmers, Eva Polverino, Megan L Crichton, et al.
The European Respiratory Journal|June 12, 2025
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trialBarry J Plant, Gisli G Einarsson, Kevin F Deasy, et al.
Microbiome|April 3, 2020
Lung function and microbiota diversity in cystic fibrosisLeah Cuthbertson, Alan W Walker, Anna E Oliver, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.
The European Respiratory Journal|September 11, 2017
European Respiratory Society guidelines for the management of adult bronchiectasisEva Polverino, Pieter C Goeminne, Melissa J McDonnell, et al.
Pageof 27